Skip to main content
. 2019 Feb 16;11(2):84–94. doi: 10.4253/wjge.v11.i2.84

Figure 1.

Figure 1

Overview of endoscopic surveillance of primary sclerosing cholangitis. AASLD: American Association for the Study of Liver Diseases; CA 19-9: Carbohydrate antigen 19-9 serum tumor marker; EGD: Esophagogastroduodenoscopy; PSC: Primary sclerosing cholangitis; PSC-IBD: Inflammatory bowel disease co-existing with primary sclerosing cholangitis.